New insights into the pathogenesis and treatment of primary pulmonary hypertension

Thorax

Volumn 56, Issue 11, 2001, Pages 888-890

  Rudarakanchana, N ^a   Trembath, R C ^b   Morrell, N W ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; DEXFENFLURAMINE; FENFLURAMINE;

DYSPNEA; FATIGUE; HUMAN; LUNG EDEMA; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SHORT SURVEY; SYNCOPE; THORAX PAIN;

ADULT; ANTICOAGULANTS; BONE MORPHOGENETIC PROTEINS; CALCIUM CHANNEL BLOCKERS; CHROMOSOMES, HUMAN, PAIR 2; EPOPROSTENOL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LINKAGE (GENETICS); MALE; MUTATION;

EID: 0034778362     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.56.11.888     Document Type: Short Survey

References (30)

1. Primary pulmonary hypertension
2. Primary pulmonary hypertension
3. Appetite-suppressant drugs and the risk of primary pulmonary hypertension
4. 5-Hydroxytryptamine and the pulmonary circulation: Receptors, transporters and the relevance to pulmonary arterial hypertension
5. Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study
6. Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension
7. Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension
8. Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension
9. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension
10. The ultrastructure of plexogenic pulmonary arteriopathy
11. TGF-β signalling in growth control, cancer, and heritable disorders
12. Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32
13. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenic protein receptor-II gene
14. Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension
15. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension
16. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor of the TGF-β family
17. Signal transduction by bone morphogenic proteins
18. Bone morphogenic proteins: From basic studies to clinical approaches
19. Bone morphogenic protein-7 (OP-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro
20. Inhibition of rat vascular smooth muscle cell proliferation in vitro and in vivo by bone morphogenic protein-2
21. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to TGF-β1 and bone morphogenic proteins
22. TGF-β signalling by Smad proteins
23. Controlling TFG-β signalling
24. Smad6 is a Smad1/5-induced Smad inhibitor
25. Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia
26. Clincial and molecular genetic features of pulmonary hypertension in hereditary hemorrhagic telangiectasia
27. Overexpression of transforming growth factor beta 1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia
28. Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene
29. Targeted disruption in murine cells reveals variable requirement for Smad4 in transforming growth factor β-related signalling
30. Hypertensive pulmonary vascular disease